Hepatitis B
Hepatitis B (viral hepatitis type B, also known as viral hepatitis B) is caused by the hepatitis B virus (HBV), and its clinical manifestations include fatigue, loss of appetite, nausea, vomiting, aversion to oil, hepatomegaly and abnormal liver function. The incidence rate is high in developing countries, and most are asymptomatic, of which one-third show clinical manifestations of liver damage. According to statistics, there are more than 280 million asymptomatic hepatitis B virus carriers (HBsAg carriers) in the world, and about 93 million in my country. Hepatitis B includes the following types: acute hepatitis B (acute icteric hepatitis, acute anicteric hepatitis), chronic hepatitis B, severe hepatitis B, cholestatic hepatitis, post-hepatitis cirrhosis, pediatric hepatitis B virus-related nephritis, neonatal hepatitis B, hepatitis B virus arthritis, etc.
-
Site of disease:
liver
-
Infectious :
Contagious
-
Frequent population:
All populations, mainly adolescents,...
-
Related symptoms:
Increased transaminase
Enlarged liver
Positive hepatitis B surface antigen (HBsAg)
Positive hepatitis B e antigen (HBeAg)
Abnormal liver function
-
Concurrent disease:
Related Drugs
Bicyclol Tablets
Indication: This product is suitable for the treatment of elevated aminotransferase caused by chronic hepatitis.
Manufacturer:
Beijing Xiehe Pharmaceutical Co., Ltd.
Bicyclol Tablets
Indication: This product is suitable for the treatment of elevated aminotransferase caused by chronic hepatitis.
Manufacturer:
Beijing Xiehe Pharmaceutical Co., Ltd.
Bicyclol Tablets
Indication: This product is suitable for the treatment of elevated aminotransferase caused by chronic hepatitis.
Manufacturer:
Beijing Xiehe Pharmaceutical Co., Ltd.
Bicyclol Tablets
Indication: This product is suitable for the treatment of elevated aminotransferase caused by chronic hepatitis.
Manufacturer:
Beijing Xiehe Pharmaceutical Co., Ltd.
Telbivudine Tablets
Indication: 1. Telbivudine is used for adult patients with chronic hepatitis B with evidence of viral replication and persistent elevation of serum aminotransferase (ALT or AST) or evidence of active liver tissue lesions. 2. This indication is based on the virological, serological, biochemical and histological response results of adult patients with chronic hepatitis B who are HBeAg-positive and HBeAg-negative and have compensated liver function who are naive to nucleoside analogs. The effect of telbivudine has not been evaluated in hepatitis B patients with concurrent HIV, HCV or HDV infection. The effect of telbivudine has not been evaluated in liver transplant patients or patients with decompensated liver disease. There are no well-designed controlled studies using telbivudine in patients with chronic hepatitis B who are resistant to nucleoside analog reverse transcriptase inhibitors, but it is estimated that it may have cross-resistance with lamivudine.
Manufacturer:
Viatris Pharmaceuticals (DALIAN) Co., Ltd.
Bifendate dripping pills
Indication: It is clinically used for patients with chronic persistent hepatitis accompanied by elevated ALT, and can also be used for elevated ALT caused by chemical poisons and drugs.
Manufacturer:
Beijing Xiehe Pharmaceutical Co., Ltd.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Changshu Leiyunshang Pharmaceutical Co., Ltd.
Oxymatrine injection
Indication: Used for the treatment of chronic hepatitis B and low white blood cell count caused by tumor radiotherapy and chemotherapy, as well as leukocytopenia caused by other reasons.
Manufacturer:
Furen Pharmaceutical Group Co., Ltd.